# Regeneron Pharmaceuticals Inc – FDA Inspection, Aug 19, 2016

Source: https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/caf7d10a-59bc-40a1-b6f6-8e3e13e51b49
Source feed: FDA_Inspections

> FDA inspection 983604 of Regeneron Pharmaceuticals Inc, August 19, 2016. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 983604
- Company Name: Regeneron Pharmaceuticals Inc
- Inspection Date: 2016-08-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1230565 - 2024-03-22](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/7df63927-1928-4995-8887-1541aa1d5420)
- [FDA Inspection 1239760 - 2024-02-16](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/be92bc21-d599-4a82-9b9d-dde944acebd3)
- [FDA Inspection 1155063 - 2021-10-25](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/f2f814f1-cd34-4b8c-9b74-fb3e6156fa2d)
- [FDA Inspection 1106821 - 2019-10-18](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/2d3aca16-4c83-4b48-914c-5f89d3ad6cde)
- FDA Inspection 1059234 - 2018-06-08

Company: https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/cd765cfa-95e6-4023-ade2-0ffa382fe2c7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c